RekrutujeFaza III
A prospective, randomized, phase III open-label clinical trial with blinded ebd-point assessment to evaluate the efficacy and safety of cyclosporine and methoterxate in chlidren…
Miasta: ŁódźWiek: do 17.99 latSponsor: Medical University Of Lodz
RekrutujeFaza III
A Study to Understand How the Study Medicine Dazukibart Works in People With Idiopathic Inflammatory Myopathies
Miasta: Białystok, Kraków, Poznań, WarszawaWiek: od 18 latSponsor: Pfizer Inc.
RekrutujeFaza II
A randomized trial comparing efficacy and safety of etanercept and methotrexate in giant cell arteritis (EFFECTA)
Miasta: Kraków, Szczecin, Warszawa, WrocławWiek: od 18 latSponsor: Wojskowy Instytut Medyczny Panstwowy Instytut Badawczy
RekrutujeFaza III
Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease
Miasta: Toruń, WarszawaWiek: do 17.99 latSponsor: AbbVie Deutschland GmbH & Co. KG
RekrutujeFaza III
Efficacy and Safety of Methotrexate Versus Placebo in Adults With Atopic Dermatitis.
Miasta: Białystok, Częstochowa, Gdańsk, Katowice i 10 innych miastWiek: od 18 latSponsor: Medac Gesellschaft fuer klinische Spezialprapaerate mbH
RekrutujeFaza III
A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Active Idiopathic Inflammatory Myopathy
Miasta: Bydgoszcz, Szczecin, ŁódźWiek: od 18 latSponsor: Argenx
RekrutujeFaza III
A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]
Miasta: Białystok, Kraków, Poznań, WarszawaWiek: od 18 latSponsor: Pfizer Inc.
RekrutujeFaza III
Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
Miasta: Białystok, Bydgoszcz, Chorzów, Gdańsk i 12 innych miastWiek: do 17.99 latSponsor: Princess Maxima Center For Pediatric Oncology
RekrutujeFaza II
International Study for Treatment of High Risk Childhood Relapsed ALL 2010
Miasta: Lublin, Wrocław, ŁódźWiek: do 17.99 latSponsor: Charite Universitaetsmedizin Berlin KöR
RekrutujeFaza II/III
International Society of Paediatric Oncology (SIOP) PNET 5 Medulloblastoma
Miasta: WarszawaWiek: do 64 latSponsor: University Medical Center Hamburg-Eppendorf